Anthony Cheung
Fundador en ENGENE HOLDINGS INC. .
Fortuna: 904 254 $ al 31/05/2024
Cargos activos de Anthony Cheung
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ENGENE HOLDINGS INC. | Director Técnico/Científico/I+D | 24/04/2023 | - |
| Fundador | 24/04/2023 | - | |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Director/Miembro de la Junta | - | - |
| Director Técnico/Científico/I+D | 16/07/2018 | - | |
| Fundador | - | - | |
| Director Ejecutivo | 25/10/2011 | 16/07/2018 | |
| Presidente | 25/10/2011 | 16/07/2018 | |
| Secretario Corporativo | 01/01/1999 | 25/05/2011 |
Historial de carrera de Anthony Cheung
Formación de Anthony Cheung.
| University of British Columbia | Undergraduate Degree |
| Tulane University School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Canadá | 4 |
| Estados Unidos | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENGENE HOLDINGS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Anthony Cheung
- Experiencia
